With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.7787-70-4,Copper(I) bromide,as a common compound, the synthetic route is as follows.
7787-70-4, 0.25 mmol (0.066 g) PPh3 was added to 15 ml CH3CN solution ofcopper(I) bromide (0.036 g, 0.25 mmol) and stirred for 1 h. Acolourless precipitate formed to which the ligand L1 (0.067 g,0.25 mmol) and CHCl3 (10 ml) were added. The mixture was stirredfor 1 h. at room temperature. Orange coloured compoundappeared. It was filtered and dried in air. Single crystals wereobtained by slow diffusion of hexane to the dilute solution of thecompound in chloroform. Yield: 0.105 g (78%). FT-IR (KBr pellet,cm1): 3059(w), 2914(w), 2853(w), 2176 (vw), 2031(w),1603(m),1474(m), 1426(m), 1305(w), 1244(w), 1184(w), 1075(m), 1027(m), 970(w), 797(w), 748(s), 688(vs), 506(s), 483(s), 421(w). Anal.found (calc. for [CuI2(Br)2(L1)(PPh3)2]): C, 57.94 (58.01%); H, 4.49(4.50%); N, 5.19 (5.17%), Cu, 11.79 (11.72%).
The synthetic route of 7787-70-4 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Patra, Goutam K.; Pal, Pankaj K.; Mondal, Jahangir; Ghorai, Anupam; Mukherjee, Anindita; Saha, Rajat; Fun, Hoong-Kun; Inorganica Chimica Acta; vol. 447; (2016); p. 77 – 86;,
Copper catalysis in organic synthesis – NCBI
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”